Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025.

Saved in:
Bibliographic Details
Title: Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025.
Authors: Gaio, Vânia1,2 (AUTHOR) vania.gaio@insa.min‐saude.pt, Henriques, Camila3 (AUTHOR), Lança, Miguel3,4 (AUTHOR), Marques, Rita5 (AUTHOR), Marques, Raquel5 (AUTHOR), Rodrigues, Marta6 (AUTHOR), Almeida, Sofia6 (AUTHOR), Sousa, Beatriz7 (AUTHOR), Freitas, Margarida7 (AUTHOR), Amaral, Diana8 (AUTHOR), Ferreira, Sara8 (AUTHOR), Azevedo, Inês9 (AUTHOR), von Hafe, Madalena9 (AUTHOR), Gonçalves, Rafaela10 (AUTHOR), Viseu, Regina10 (AUTHOR), Bandeira, Teresa11 (AUTHOR), Constant, Carolina11 (AUTHOR), Malato, Madalena12 (AUTHOR), Carvalho, Inês12 (AUTHOR), Rodrigues, Jorge13 (AUTHOR)
Source: Influenza & Other Respiratory Viruses. Dec2025, Vol. 19 Issue 12, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17502640
DOI:10.1111/irv.70186